VaramirStart free · no cardSign in
LLY as of Oct 30 · 20:31 ET
LLYNYSEPharmaceutical Preparations

ELI Lilly & Co · Brief

Next report

95 days

Feb 3 · before openest.Q4 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
5 of 8≥ implied
avg implied
±5.2%
avg realized
±8.1%
Feb 6 '25±4.5%▲+3.35%×0.75
May 1 '25±4.3%▼−11.66%×2.68
Aug 7 '25±5.5%▼−14.14%×2.56
Q3 FY25±4.8%▲+3.81%×0.80
Feb 4 '26±6.1%▲+10.33%×1.70
Q1 FY26±5.3%▲+9.80%×1.84
Q2 FY26±6.2%▲+4.86%×0.78
Q3 FY26±5.1%▲+6.63%×1.29
quarterimplied−15%0+15%realized×
Q3 FY26±5.1%▲+6.63%×1.29
Q2 FY26±6.2%▲+4.86%×0.78
Q1 FY26±5.3%▲+9.80%×1.84
Feb '26±6.1%▲+10.33%×1.70
Q3 FY25±4.8%▲+3.81%×0.80
Aug '25±5.5%▼−14.14%×2.56
2 older reports
May '25±4.3%▼−11.66%×2.68
Feb '25±4.5%▲+3.35%×0.75
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Feb 3 report · est.

—

Linked exposure

LLY report session

Suppliers 1

SDGRSchrodinger×0.42
× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 20unusualUnusual volume: ×2.83 RVOL at 10:31 ET.Source
Oct 15impliedImplied move: ±6.6% into Oct 29 earnings (Oct 15 close).Source
Oct 15unusualUnusual volume: ×2.72 RVOL at 10:31 ET.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.